MX2015012416A - Compuestos heterociclicos y sus usos. - Google Patents

Compuestos heterociclicos y sus usos.

Info

Publication number
MX2015012416A
MX2015012416A MX2015012416A MX2015012416A MX2015012416A MX 2015012416 A MX2015012416 A MX 2015012416A MX 2015012416 A MX2015012416 A MX 2015012416A MX 2015012416 A MX2015012416 A MX 2015012416A MX 2015012416 A MX2015012416 A MX 2015012416A
Authority
MX
Mexico
Prior art keywords
heterocyclic compounds
preparation
methods
pharmaceutical formulations
certain pharmaceutical
Prior art date
Application number
MX2015012416A
Other languages
English (en)
Inventor
Brett Caldwell
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2015012416A publication Critical patent/MX2015012416A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Se proporcionan ciertas formulaciones farmacéuticas de omecamtiv mecarbilo y métodos para su preparación y uso.
MX2015012416A 2013-03-14 2014-03-14 Compuestos heterociclicos y sus usos. MX2015012416A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361785492P 2013-03-14 2013-03-14
PCT/US2014/027061 WO2014152198A1 (en) 2013-03-14 2014-03-14 Heterocyclic compounds and their uses

Publications (1)

Publication Number Publication Date
MX2015012416A true MX2015012416A (es) 2016-04-07

Family

ID=50439524

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012416A MX2015012416A (es) 2013-03-14 2014-03-14 Compuestos heterociclicos y sus usos.

Country Status (9)

Country Link
US (1) US9895308B2 (es)
EP (1) EP2968180B1 (es)
JP (2) JP6634368B2 (es)
AU (1) AU2014240104B2 (es)
CA (1) CA2902424A1 (es)
ES (1) ES2733340T3 (es)
HK (1) HK1220363A1 (es)
MX (1) MX2015012416A (es)
WO (1) WO2014152198A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2663663C2 (ru) 2013-03-14 2018-08-08 Эмджен Инк. Соль омекамтива мекарбила и способ ее получения
RS62328B1 (sr) * 2017-06-30 2021-10-29 Amgen Inc Sinteza omekamtiv mekarbila
CA3068588A1 (en) * 2017-06-30 2019-01-03 Amgen Inc. Methods of treating heart failure with cardiac sarcomere activators
BR112020004800A2 (pt) 2017-09-13 2020-09-24 Amgen Inc. compostos de bisamida ativantes do sarcômero e seus usos
JP2021534138A (ja) 2018-08-17 2021-12-09 アムジエン・インコーポレーテツド オメカムチブメカルビルの塩及び結晶形態
WO2021136477A1 (zh) * 2020-01-03 2021-07-08 苏州科睿思制药有限公司 化合物i二盐酸盐的共晶及其制备方法和用途
US20230090391A1 (en) * 2020-02-10 2023-03-23 Amgen Inc. Omecamtiv mecarbil tablet
WO2022192414A2 (en) 2021-03-10 2022-09-15 Amgen Inc. Synthesis of omecamtiv mecarbil

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612059A (en) 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
BR0016708A (pt) * 1999-12-23 2002-10-08 Pfizer Prod Inc Forma de dosagem de droga baseada em hidrogel
US8197846B2 (en) 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
MY144470A (en) 2004-06-17 2011-09-30 Cytokinetics Inc Compounds, compositions and methods
AR058347A1 (es) * 2005-12-15 2008-01-30 Cytokinetics Inc Entidades quimias composiciones y metodos

Also Published As

Publication number Publication date
HK1220363A1 (zh) 2017-05-05
CA2902424A1 (en) 2014-09-25
JP6634368B2 (ja) 2020-01-22
AU2014240104A1 (en) 2015-09-10
EP2968180A1 (en) 2016-01-20
EP2968180B1 (en) 2019-04-24
AU2014240104B2 (en) 2018-11-08
JP2019048830A (ja) 2019-03-28
US20160015628A1 (en) 2016-01-21
WO2014152198A1 (en) 2014-09-25
JP2016513678A (ja) 2016-05-16
ES2733340T3 (es) 2019-11-28
US9895308B2 (en) 2018-02-20

Similar Documents

Publication Publication Date Title
PH12019500176A1 (en) Heterocyclic compounds and ther uses
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
IL240291A0 (en) History of pyridazinone and pharmaceutical preparations containing them
IL243608A0 (en) Substances with antiviral activity, preparations containing them and their uses
PL2829539T3 (pl) Nowe pochodne pirolu, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające
IL264259A (en) Oral formulations of pyrrolidine derivatives
MX2015012416A (es) Compuestos heterociclicos y sus usos.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
TN2015000411A1 (en) Ceftolozane antibiotic compositions
EP3038465A4 (en) Oral pharmaceutical formulation of omarigliptin
CL2017000587A1 (es) Derivados de tetrahidroquinolina como inhibidores de bromodominio
EP3049389A4 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
HK1218079A1 (zh) 亞硝酸鹽的藥物製劑及其用途
UY34829A (es) Nueva dosificación y formulación
EP3049077A4 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
HK1217670A1 (zh) 調配物、其製造方法和用途
PT3143032T (pt) Novos derivados terapêuticos de oxazafosforinas e as suas utilizações terapêuticas
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
TWD173316S (zh) 義肢
MY180947A (en) Ceftolozane antibiotic compositions

Legal Events

Date Code Title Description
FG Grant or registration